基于热毒理论探讨清瘟败毒饮联合血净对脓毒症巨噬细胞极化的影响

Exploring effect of Qingwen Baidu Decoction combined with blood purification on macrophage polarization in sepsis based on heat-toxicity theory

  • 摘要:
    目的 基于“热毒”理论探究清瘟败毒饮加减联合血液净化对脓毒症患者巨噬细胞极化相关因子的影响, 并探究其作用机制。
    方法 选择2023年1月-2024年12月于佛山市中医院三水医院就诊的脓毒症患者80例为研究对象, 并随机平均分为对照组和试验组。对照组接受基础支持治疗联合血液净化干预, 试验组则在上述方案基础上叠加口服清瘟败毒饮汤剂, 比较两组临床资料、治疗第1、3、7天急性生理与慢性健康评分(APACHEⅡ)、序贯器官衰竭评分(SOFA)、中医证候积分及巨噬细胞极化相关因子白细胞介素(IL)-4、IL-6、IL-10、肿瘤坏死因子-α(TNF-α)、干扰素-γ(IFN-γ)、转化生长因子-β(TGF-β)动态变化及疗效。
    结果 试验组治疗第7天APACHEⅡ评分(12.16±2.41)分vs. (15.62±2.56)分、SOFA评分(3.83±1.24)分vs. (5.58±1.59)分、中医证候积分(11.64±3.13)分vs. (15.84±4.02)分均低于对照组(P<0.05)。试验组治疗第1天、第3天、第7天IFN-γ水平低于对照组, 治疗第3天、第7天IL-6、TNF-α水平均低于对照组(P<0.05);治疗第1天、第3天、第7天IL-4、IL-10升高(P<0.05), 第3天、第7天TGF-β高于对照组(P<0.05)。试验组治疗总有效率(95.00%)高于对照组(87.50%)(P<0.05)。
    结论 清瘟败毒饮联合血液净化治疗可提升脓毒症患者临床疗效, 通过调节巨噬细胞极化(抑制M1型因子IFN-γ/TNF-α, 促进M2型因子IL-4/IL-10/TGF-β)维持免疫平衡, 具有重要的临床应用价值。

     

    Abstract:
    OBJECTIVE To investigate the impact of Qingwen Baidu Decoction (antipyretic and antitoxic decoction) combined with blood purification on macrophage polarization-related factors in patients with sepsis based on the "heat-toxicity" theory, and explore its mechanism.
    METHODS A total of 80 patients with sepsis who were admitted to Sanshui Hospital of Foshan Hospital of Traditional Chinese Medicine from Jan. 2023 to Dec. 2024 were selected as the study subjects and randomly divided into a control group and an experimental group. The control group received basic supportive treatment combined with blood purification intervention, while the experimental group received an additional oral administration of Qingwen Baidu Decoction on the basis of the above regimen. The clinical data, acute physiology and chronic health evaluation Ⅱ (APACHE Ⅱ) scores, sequential organ failure assessment (SOFA) scores, traditional Chinese medicine (TCM) syndrome scores and dynamic changes in macrophage polarization-related factors interleukin (IL)-4, IL-6, IL-10, tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ) and transforming growth factor-β (TGF-β)on the 1 st, 3rd and 7th days and the therapeutic efficacy were compared between the two groups.
    RESULTS On the 7th day of treatment, the APACHE Ⅱ score (12.16±2.41 vs. 15.62±2.56), SOFA score (3.83±1.24 vs. 5.58±1.59) and TCM syndrome score (11.64±3.13 vs. 15.84±4.02) in the experimental group were all lower than those in the control group (P < 0.05). The levels of IFN-γ on the 1 st, 3rd and 7th days of treatment in the experimental group were lower than those in the control group, and the levels of IL-6 and TNF-α on the 3rd and 7th days of treatment were also lower than those in the control group (P < 0.05). The levels of IL-4 and IL-10 increased on the 1 st, 3rd and 7th days of treatment(P < 0.05), and the level of TGF-β on the 3rd and 7th days was higher in the experiment group than that in the control group (P < 0.05). The total effective rate of treatment in the experimental group (95.00%) was higher than that in the control group (87.50%) (P < 0.05).
    CONCLUSION The combination of Qingwen Baidu Decoction and blood purification therapy can enhance the clinical therapeutic efficacy in patients with sepsis by regulating macrophage polarization (suppressing M1-type factors IFN-γ/TNF-α and promoting M2-type factors IL-4/IL-10/TGF-β), thereby maintaining immune balance, which demonstrates significant clinical application value.

     

/

返回文章
返回